How Do We Continue Treatment in Patients With Type 2 Diabetes When Therapeutic Goals Are Not Reached With Oral Antidiabetes Agents and Lifestyle? Incretin versus insulin treatment

por Gallwitz, Baptist, Bretzel, Reinhard G.
Publicado 2013

Anti-Inflammatory Thalidomide Improves Islet Grafts Survival and Functions in a Xenogenic Environment

por Chen, Chunguang, Kuehn, Carina, Bretzel, Reinhard G., Linn, Thomas
Publicado 2009

Correction: Anti-Inflammatory Thalidomide Improves Islet Grafts Survival and Functions in a Xenogenic Environment

por Chen, Chunguang, Kuehn, Carina, Bretzel, Reinhard G., Linn, Thomas
Publicado 2009

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond

por Bretzel, Reinhard G., Eckhard, Michael, Landgraf, Wolfgang, Owens, David R., Linn, Thomas
Publicado 2009

Randomised prospective study for the effect of therapy on residual beta cell function in type-1 diabetes mellitus [ISRCTN70703138]

por Linn, Thomas, Mann, Marion, Mann, Markus, Bretzel, Reinhard G, Boedeker, Rolf H
Publicado 2003

Inhibition of Gelatinase B (Matrix Metalloprotease-9) Activity Reduces Cellular Inflammation and Restores Function of Transplanted Pancreatic Islets

por Lingwal, Neelam, Padmasekar, Manju, Samikannu, Balaji, Bretzel, Reinhard G., Preissner, Klaus T., Linn, Thomas
Publicado 2012

Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508

por Home, Philip, Riddle, Matthew, Cefalu, William T., Bailey, Clifford J., Bretzel, Reinhard G., del Prato, Stefano, Leroith, Derek, Schernthaner, Guntram, van Gaal, Luc, Raz, Itamar
Publicado 2014

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?

por Home, Philip, Riddle, Matthew, Cefalu, William T., Bailey, Clifford J., Bretzel, Reinhard G., del Prato, Stefano, Leroith, Derek, Schernthaner, Guntram, van Gaal, Luc, Raz, Itamar
Publicado 2014